Cargando…

Editorial: The CB2 Cannabinoid System: A New Strategy in Neurodegenerative Disorder and Neuroinflammation

Detalles Bibliográficos
Autores principales:	Contino, Marialessandra, Capparelli, Elena, Colabufo, Nicola A., Bush, Ashley I.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2017
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5382166/ https://www.ncbi.nlm.nih.gov/pubmed/28428743 http://dx.doi.org/10.3389/fnins.2017.00196

Ejemplares similares

Small and Innovative Molecules as New Strategy to Revert MDR
por: Zinzi, Laura, et al.
Publicado: (2014)

ABC transporters in CSCs membranes as a novel target for treating tumor relapse
por: Zinzi, Laura, et al.
Publicado: (2014)

Targeting Cannabinoid CB(2) Receptors in the Central Nervous System. Medicinal Chemistry Approaches with Focus on Neurodegenerative Disorders
por: Navarro, Gemma, et al.
Publicado: (2016)

Cannabinoid CB2 Receptors in Neurodegenerative Proteinopathies: New Insights and Therapeutic Potential
por: Vuic, Barbara, et al.
Publicado: (2022)

Editorial: The relationship of neuroinflammation with aging and neurodegenerative diseases
por: Wang, Guohao, et al.
Publicado: (2022)

Editorial: Cannabinoids in neuroinflammation, neurodegeneration and pain: Focus on non-neuronal cells
por: Vecchiarelli, Haley A., et al.
Publicado: (2022)

Receptor-Drug Interaction: Europium Employment for Studying the Biochemical Pathway of G-Protein-Coupled Receptor Activation
por: Antonio, Colabufo Nicola, et al.
Publicado: (2007)

New Strategies to Overcome Resistance to Chemotherapy and Immune System in Cancer
por: Riganti, Chiara, et al.
Publicado: (2019)

Editorial: Therapeutic potential of the cannabinoid CB2 receptor
por: Smoum, Reem, et al.
Publicado: (2022)

Protein Interactors and Trafficking Pathways That Regulate the Cannabinoid Type 1 Receptor (CB1R)
por: Fletcher-Jones, Alexandra, et al.
Publicado: (2020)

PB28, the Sigma-1 and Sigma-2 Receptors Modulator With Potent Anti–SARS-CoV-2 Activity: A Review About Its Pharmacological Properties and Structure Affinity Relationships
por: Abate, Carmen, et al.
Publicado: (2020)

Corrigendum: Protein Interactors and Trafficking Pathways That Regulate the Cannabinoid Type 1 Receptor (CB1R)
por: Fletcher-Jones, Alexandra, et al.
Publicado: (2020)

Role of Specialized Pro-resolving Mediators in Reducing Neuroinflammation in Neurodegenerative Disorders
por: Ponce, Jana, et al.
Publicado: (2022)

Healthy lifestyles and wellbeing reduce neuroinflammation and prevent neurodegenerative and psychiatric disorders
por: Kip, Elodie, et al.
Publicado: (2023)

Vascular Dysfunction in a Transgenic Model of Alzheimer's Disease: Effects of CB1R and CB2R Cannabinoid Agonists
por: Navarro-Dorado, Jorge, et al.
Publicado: (2016)

An innovative small molecule for promoting neuroreparative strategies
por: Colabufo, Nicola Antonio, et al.
Publicado: (2018)

Editorial: Neuropsychology and Neuropsychiatry of Neurodegenerative Disorders
por: Menéndez-González, Manuel, et al.
Publicado: (2015)

Editorial: Multimorbidity in the context of neurodegenerative disorders
por: Linden, Rafael, et al.
Publicado: (2022)

Neuroinflammation: A Possible Link Between Chronic Vascular Disorders and Neurodegenerative Diseases
por: Moyse, Emmanuel, et al.
Publicado: (2022)

Editorial: Molecular modulators of GPCRs signal transduction
por: Vrecl, Milka, et al.
Publicado: (2023)

Editorial: Brain Injury as a Neurodegenerative Disorder
por: Green, Robin E. A.
Publicado: (2016)

Editorial: Neuronal network dysfunction in neurodegenerative disorders
por: Kwakowsky, Andrea, et al.
Publicado: (2023)

Cannabinoid Receptor 2 Signaling in Neurodegenerative Disorders: From Pathogenesis to a Promising Therapeutic Target
por: Cassano, Tommaso, et al.
Publicado: (2017)

Inhibition of hERG potassium channel by the antiarrhythmic agent mexiletine and its metabolite m-hydroxymexiletine
por: Gualdani, Roberta, et al.
Publicado: (2015)

Editorial: Gene Silencing and Editing Strategies for Neurodegenerative Diseases
por: Nóbrega, Clévio, et al.
Publicado: (2018)

Effect of Neuroinflammation on Synaptic Organization and Function in the Developing Brain: Implications for Neurodevelopmental and Neurodegenerative Disorders
por: Mottahedin, Amin, et al.
Publicado: (2017)

The Dopamine and Cannabinoid Interaction in the Modulation of Emotions and Cognition: Assessing the Role of Cannabinoid CB1 Receptor in Neurons Expressing Dopamine D1 Receptors
por: Terzian, Ana Luisa, et al.
Publicado: (2011)

Cannabinoid CB1 and Dopamine D1 Receptors Partnership in the Modulation of Emotional Neural Processing
por: Akirav, Irit, et al.
Publicado: (2011)

Dichotomic Hippocampal Transcriptome After Glutamatergic vs. GABAergic Deletion of the Cannabinoid CB1 Receptor
por: Pascual Cuadrado, Diego, et al.
Publicado: (2021)

Editorial: Metabolic Alterations in Neurodegenerative Disorders
por: Freude, Kristine K., et al.
Publicado: (2022)

Editorial: Targeting the endocannabinoidome in neurodegenerative disorders
por: Ishiguro, Hiroki
Publicado: (2023)

Cannabinoid CB(1) and CB(2) Receptor Signaling and Bias
por: Ibsen, Mikkel Søes, et al.
Publicado: (2017)

Viruses and Endogenous Retroviruses as Roots for Neuroinflammation and Neurodegenerative Diseases
por: Römer, Christine
Publicado: (2021)

The interaction of celecoxib with MDR transporters enhances the activity of mitomycin C in a bladder cancer cell line
por: Pagliarulo, Vincenzo, et al.
Publicado: (2013)

Editorial: Complexity and Connectivity: Functional Signatures of Neurodegenerative Disorders
por: Gómez, Carlos, et al.
Publicado: (2020)

Editorial: Regulation of inflammation and metabolism in retinal neurodegenerative disorders
por: Leinonen, Henri, et al.
Publicado: (2022)

Editorial: Neuroinflammation and Cognition
por: Kumar, Ashok
Publicado: (2018)

Editorial: The Canonical and Non-Canonical Endocannabinoid System as a Target in Cancer and Acute and Chronic Pain
por: Contino, Marialessandra, et al.
Publicado: (2020)

New Insights and Potential Therapeutic Targeting of CB2 Cannabinoid Receptors in CNS Disorders
por: Kibret, Berhanu Geresu, et al.
Publicado: (2022)

Cannabigerol Action at Cannabinoid CB(1) and CB(2) Receptors and at CB(1)–CB(2) Heteroreceptor Complexes
por: Navarro, Gemma, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_tmo0mf93sgthfpi6bul6h6serq